S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:DOCPhysicians Realty Trust Earnings Date, Estimates & History

$18.36
+0.13 (+0.71 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.20
Now: $18.36
$18.42
50-Day Range
$16.66
MA: $17.55
$18.50
52-Week Range
$11.01
Now: $18.36
$20.78
Volume969,600 shs
Average Volume2.65 million shs
Market Capitalization$3.82 billion
P/E Ratio40.80
Dividend Yield5.01%
Beta0.85

Earnings

Physicians Realty Trust (NYSE:DOC) Earnings Information

Physicians Realty Trust last announced its quarterly earnings data on August 6th, 2020. The real estate investment trust reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. The company had revenue of $109.07 million for the quarter, compared to analysts' expectations of $106.84 million. Its quarterly revenue was up 14.9% on a year-over-year basis. Physicians Realty Trust has generated $0.99 earnings per share over the last year and currently has a price-to-earnings ratio of 40.8. Physicians Realty Trust has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

Physicians Realty Trust Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Physicians Realty Trust (NYSE:DOC) Earnings Estimates

2020 EPS Consensus Estimate: $1.07
2021 EPS Consensus Estimate: $1.13
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20205$0.26$0.28$0.27
Q2 20205$0.26$0.27$0.26
Q3 20205$0.26$0.28$0.27
Q4 20205$0.27$0.28$0.27
Q1 20214$0.26$0.29$0.28
Q2 20214$0.28$0.29$0.28
Q3 20214$0.28$0.30$0.29
Q4 20213$0.27$0.29$0.28
Q1 20221$0.27$0.27$0.27

Physicians Realty Trust (NYSE DOC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020
(Estimated)
       
8/6/20206/30/2020$0.26$0.27$0.08$106.84 million$109.07 millionTranscript
5/7/20203/31/2020$0.26$0.07$0.07$108.64 million$107.43 millionTranscript
2/26/2020Q4 2019$0.27$0.22$0.22$109.57 million$107.42 millionTranscript
11/6/2019Q3 2019$0.26$0.08$0.08$105.01 million$107.59 millionTranscript
8/7/20196/30/2019$0.26$0.04$0.04$105.92 million$94.90 millionListen
5/1/20193/31/2019$0.26$0.25$0.06$104.27 million$105.40 millionN/A
2/27/2019Q4 2018$0.27$0.06$0.06$104.75 million$105.31 millionN/A
11/2/20189/30/2018$0.27$0.28$0.12$103.70 million$105.03 millionTranscript
8/2/2018Q2 2018$0.28$0.06$0.06$104.60 million$106.99 millionN/A
5/4/2018Q1 2018$0.27$0.06$0.06$101.70 million$105.20 millionN/A
2/28/2018Q4 2017$0.27$0.27$0.05$98.56 million$97.30 millionTranscript
11/3/2017Q3 2017$0.27$0.26$0.07$90.21 million$93.00 millionN/A
8/3/2017Q2 2017$0.23$0.24$0.06$80.48 million$76.60 millionListen
5/3/2017Q1 2017$0.30$0.28$0.04$77.57 million$76.70 millionListen
2/24/2017Q416$0.30$0.06$0.06$74.07 million$73.70 millionN/A
11/2/2016Q316$0.28$0.27$0.07$66.21 million$70.00 millionN/A
8/3/2016Q216$0.23$0.22$0.05$50.82 million$53.20 millionN/A
5/5/2016Q116$0.23$0.22$0.04$43.64 million$44.10 millionN/A
2/29/2016Q415$0.26$0.26$0.06$39.20 million$40.40 millionListen
11/6/2015Q315$0.26$0.26$0.05$31.68 million$34.90 millionN/A
8/7/2015Q215$0.24$0.21$0.04$27.41 million$29.70 millionN/A
5/7/2015Q115$0.22$0.20($0.01)$22.33 million$24.50 millionN/A
3/4/2015Q414$0.22$0.22$0.04$18.27 million$19.40 millionN/A
11/12/2014Q3 14$0.20$0.17($0.06)$12.97 million$14.16 millionN/A
8/13/2014Q114$0.23$0.17($0.02)$10.40 million$11.40 millionN/A
5/7/2014Q1 2014$0.17$0.12($0.15)$6.75 million$7.99 millionN/A
2/27/2014Q4 2013$0.14($0.04)($0.04)$6.12 million$6.40 millionN/A
11/6/2013Q3 2013$0.03($0.10)($0.10)$3.45 million$3.71 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.